Blueprint for schistosomiasis vaccine development (Q34646730)

3 August 2017

1 reference

title

Blueprint for schistosomiasis vaccine development (English)

1 reference

3 August 2017

0 references

1 reference

Robert Bergquist

1

1 reference

3 August 2017

Maged Al-Sherbiny

series ordinal

2

1 reference

3 August 2017

Rashida Barakat

series ordinal

3

1 reference

3 August 2017

Richard Olds

series ordinal

4

1 reference

3 August 2017

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

82

1 reference

3 August 2017

183-192

1 reference

3 August 2017

2

1 reference

Functional diversity of helper T lymphocytes

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Schistosomiasis research funding: the TDR (Special Programme for Research and Training in Tropical Diseases) contribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Schistosomiasis vaccine development: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Schistosomiasis vaccine:research to development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Immunity to schistosomes: progress toward vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Vaccine strategies against schistosomiasis: from concepts to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Human schistosomiasis: potential long-term consequences of vaccination programmes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Praziquantel: is there real resistance and are there alternatives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

The global status of schistosomiasis and its control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Parasite vaccines--a reality?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Cloning of a cDNA encoding a surface antigen of Schistosoma mansoni schistosomula recognized by sera of vaccinated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Schistosoma and related genera: Acquired resistance in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Experimental models of immunization against schistosomes: lessons for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Effector functions of activated macrophages against parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Schistosoma japonicum infection in the pig as a model for human schistosomiasis japonica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Helper T cell subsets: heterogeneity, functions and development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

The search for a vaccine against schistosomiasis--a difficult path but an achievable goal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Praziquantel--quality, dosages and markers of resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Dilemmas in drug development for tropical diseases. Experiences with praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Human immune responses to Schistosoma mansoni vaccine candidate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Regulation of immunity to parasites by T cells and T cell-derived cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Resistance to reinfection after treatment of urinary schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Human schistosomiasis: potential consequences of vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900048-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(02)00048-7

1 reference

3 August 2017

1 reference